Erudio Health provides AI agents designed to support medical affairs teams, particularly Medical Science Liaisons (MSLs), by continuously monitoring and analyzing healthcare professional (HCP) conversations from podcasts, YouTube, and social media. The platform addresses the challenge of missed or delayed insights by delivering tailored weekly reports, real-time territory alerts, and on-demand answers, ensuring MSLs have up-to-date context for interactions regarding drugs and clinical trials.
The system works by configuring AI agents based on the user’s therapeutic areas, drugs, clinical trials, and MSL territories. These agents collect and process HCP discussions, generating individualized weekly reports for each MSL, with heightened daily reporting during major conferences such as ASH and ASCO. Reports are available in multiple formats, including private podcast summaries for on-the-go listening, as well as ready-to-share PDFs and PowerPoint files. Competitive drug and trial analysis is provided based on actual HCP conversations, rather than simple keyword tracking.
Territory alerts notify MSLs within 24 hours when HCPs in their specific regions mention relevant trials, including full conversation context, involved HCPs, and shared articles. The platform maps MSL territories to HCP practice locations using zip codes and NPI data, allowing for precise regional targeting. Stakeholder mapping features display HCP specialties and influence, aiding in impact estimation. On-demand answers are available via chat, with responses cited and referenced for verification, and the underlying data is updated hourly from thousands of hours of media content.
Erudio Health also offers features for commercial and strategy teams seeking real-time competitive intelligence and for CME providers, enabling citation-first chat experiences, objective alignment, and outcomes analytics. Security diligence is supported by a SOC 2 Type I report available under NDA. The platform is delivered as a service, with no mention of specific pricing or licensing details in the available information.
In the Other AI space, Erudio Health takes a focused approach. It focuses on ensuring medical affairs teams never miss critical HCP conversations by providing timely, tailored insights and alerts. It is built as a B2B product for medical affairs teams and MSLs in pharma. Erudio Health is sold on an enterprise-only basis. The product ships for the web.
Erudio Health builds and maintains Erudio Health, and the product first shipped in 2024. Key capabilities include AI agents, medical insights, and real-time alerts.
Latest indexed changes and source events
Other apps tracked under the same category.
